What is Zepbound?
Zepbound is a medication approved for chronic weight management in adults with obesity or overweight with at least one weight-related condition [1]. It is an injection containing tirzepatide, which is also the active ingredient in Mounjaro, a drug used to treat type 2 diabetes [2].
How does Zepbound work?
Tirzepatide is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist [1]. By activating these receptors, it helps to regulate appetite and food intake, leading to weight loss [3].
What are the alternatives to Zepbound for weight loss?
Several medications are approved for chronic weight management, functioning through similar or different mechanisms. These include:
* GLP-1 Receptor Agonists: Semaglutide, sold under brand names like Wegovy and Ozempic, is another GLP-1 receptor agonist that has shown significant results in weight loss [4]. Liraglutide (Saxenda) is also a GLP-1 receptor agonist used for weight management [5].
* Combination Therapies: Phentermine/topiramate (Qsymia) is a combination medication that works by suppressing appetite and increasing metabolism [6]. Naltrexone/bupropion (Contrave) is another combination that targets appetite control and reward pathways [7].
* Other Medications: Orlistat (Xenical, Alli) is a lipase inhibitor that reduces fat absorption [8]. Metreleptin (Myalept) is approved for generalized lipodystrophy [9].
How do Zepbound and Wegovy compare?
Both Zepbound (tirzepatide) and Wegovy (semaglutide) are injectable medications approved for chronic weight management and are considered highly effective [1, 4]. Tirzepatide targets both GIP and GLP-1 receptors, while semaglutide primarily targets the GLP-1 receptor [1, 4]. Clinical trials have shown that tirzepatide can lead to greater weight loss compared to semaglutide in some studies [3]. However, the choice between them may depend on individual patient response, tolerability, and physician recommendation.
What are the potential side effects of Zepbound?
The most common side effects of Zepbound include gastrointestinal issues such as nausea, diarrhea, vomiting, constipation, abdominal pain, and decreased appetite [1]. More serious, though less common, side effects can include pancreatitis, gallbladder problems, kidney issues, and thyroid C-cell tumors [1].
What is the clinical data supporting Zepbound's effectiveness?
Clinical trials for Zepbound have demonstrated significant weight loss in participants compared to placebo [1]. For example, the SURMOUNT-4 trial showed that participants treated with tirzepatide achieved an average of 18.5% additional body weight loss over 72 weeks [1].
When does Zepbound's patent expire?
Information regarding specific patent expiry dates for Zepbound (tirzepatide) can be found through resources like DrugPatentWatch.com [10]. Patents protect new drug innovations, and their expiry allows for the development of generic or biosimilar versions of the medication.
Who manufactures Zepbound?
Zepbound is manufactured by Eli Lilly and Company [1].